See more : Toyo Logistics Co., Ltd. (9306.T) Income Statement Analysis – Financial Results
Complete financial analysis of Wenzhou Kangning Hospital Co., Ltd. (2120.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Wenzhou Kangning Hospital Co., Ltd., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Shigematsu Works Co., Ltd. (7980.T) Income Statement Analysis – Financial Results
- Unisys Corporation (USY1.DE) Income Statement Analysis – Financial Results
- International Luxury Products Inc. (ILXP) Income Statement Analysis – Financial Results
- Toscana Aeroporti S.p.A. (TYA.MI) Income Statement Analysis – Financial Results
- Exploits Discovery Corp. (NFLD.CN) Income Statement Analysis – Financial Results
Wenzhou Kangning Hospital Co., Ltd. (2120.HK)
About Wenzhou Kangning Hospital Co., Ltd.
Wenzhou Kangning Hospital Co., Ltd. operates and manages a network of healthcare facilities in the People's Republic of China. It primarily focuses on providing psychiatric specialty care. The company also provides property leasing and sale services; and software and information technology services, as well as hospital management, forensic authentication, and medical services. It is also engaged in pharmaceutical retail. The company was formerly known as Wenzhou City Kangning Psychiatric Rehabilitation Hospital and changed its name to Wenzhou Kangning Hospital Co., Ltd. in October 2014. Wenzhou Kangning Hospital Co., Ltd. was founded in 1996 and is headquartered in Wenzhou, the People's Republic of China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.60B | 1.48B | 1.30B | 1.03B | 860.69M | 745.97M | 666.44M | 415.41M | 343.67M | 296.30M | 226.36M | 170.81M |
Cost of Revenue | 1.19B | 1.13B | 968.43M | 728.70M | 656.18M | 493.73M | 449.33M | 273.24M | 213.29M | 181.31M | 140.27M | 112.21M |
Gross Profit | 411.14M | 352.93M | 329.00M | 302.58M | 204.51M | 252.24M | 217.10M | 142.17M | 130.39M | 114.98M | 86.09M | 58.60M |
Gross Profit Ratio | 25.76% | 23.77% | 25.36% | 29.34% | 23.76% | 33.81% | 32.58% | 34.22% | 37.94% | 38.81% | 38.03% | 34.31% |
Research & Development | 32.47M | 33.03M | 27.96M | 20.97M | 6.02M | 5.73M | 1.57M | 2.88M | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 61.84M | 59.29M | 41.32M | 125.06M | 123.34M | 98.00M | 91.75M | 78.53M | 62.52M | 45.61M | 32.31M | 28.33M |
Selling & Marketing | 6.71M | 15.00M | 10.43M | 8.07M | 7.98M | 5.14M | 1.75M | 3.14M | 1.97M | 2.09M | 4.88M | 2.61M |
SG&A | 68.56M | 74.30M | 51.75M | 133.13M | 131.32M | 103.14M | 93.51M | 81.68M | 64.49M | 47.70M | 38.99M | 31.15M |
Other Expenses | 208.66M | 136.59M | 126.83M | -3.91M | -3.10M | -319.38K | -1.63M | -204.00K | -9.00K | -30.00K | 0.00 | 0.00 |
Operating Expenses | 309.68M | 243.92M | 206.54M | 150.20M | 134.24M | 99.34M | 99.65M | 73.11M | 61.42M | 47.01M | 34.03M | 30.27M |
Cost & Expenses | 1.49B | 1.38B | 1.17B | 878.90M | 790.42M | 593.07M | 548.98M | 346.35M | 274.71M | 228.33M | 174.30M | 142.48M |
Interest Income | 5.27M | 2.76M | 1.69M | 4.77M | 5.18M | 3.68M | 4.96M | 5.67M | 1.14M | 749.00K | 4.49M | 10.37M |
Interest Expense | 39.94M | 45.15M | 36.27M | 26.56M | 26.56M | 8.85M | 13.84M | 5.75M | 4.00M | 121.00K | 0.00 | 0.00 |
Depreciation & Amortization | 113.55M | 114.21M | 104.58M | 88.26M | 75.54M | 38.85M | 26.33M | 30.61M | 21.23M | 14.60M | 11.68M | 7.53M |
EBITDA | 252.67M | 174.97M | 211.31M | 189.39M | 155.79M | 160.12M | 104.56M | 115.01M | 95.41M | 83.16M | 63.47M | 35.97M |
EBITDA Ratio | 15.83% | 14.52% | 16.29% | 22.23% | 17.33% | 24.17% | 18.24% | 29.87% | 27.80% | 28.11% | 28.04% | 21.06% |
Operating Income | 101.45M | 101.41M | 92.50M | 140.96M | 73.62M | 105.77M | 73.25M | 78.02M | 68.83M | 67.82M | 51.78M | 28.44M |
Operating Income Ratio | 6.36% | 6.83% | 7.13% | 13.67% | 8.55% | 14.18% | 10.99% | 18.78% | 20.03% | 22.89% | 22.88% | 16.65% |
Total Other Income/Expenses | -2.27M | -67.49M | 3.19M | -17.67M | -18.09M | -20.73M | -37.98M | 14.12M | 1.35M | 749.00K | -4.21M | -10.48M |
Income Before Tax | 99.18M | 15.60M | 95.70M | 87.90M | 55.52M | 106.91M | 69.86M | 92.14M | 70.17M | 68.57M | 47.58M | 17.96M |
Income Before Tax Ratio | 6.21% | 1.05% | 7.38% | 8.52% | 6.45% | 14.33% | 10.48% | 22.18% | 20.42% | 23.14% | 21.02% | 10.52% |
Income Tax Expense | 12.25M | 26.57M | 54.83M | 28.95M | 17.30M | 31.94M | 22.03M | 26.59M | 18.55M | 17.37M | 11.38M | 4.73M |
Net Income | 85.95M | -10.97M | 44.04M | 55.77M | 38.23M | 80.60M | 49.07M | 68.83M | 55.71M | 51.20M | 36.19M | 13.23M |
Net Income Ratio | 5.38% | -0.74% | 3.39% | 5.41% | 4.44% | 10.80% | 7.36% | 16.57% | 16.21% | 17.28% | 15.99% | 7.75% |
EPS | 1.15 | -0.15 | 0.61 | 0.77 | 0.52 | 1.10 | 0.67 | 0.94 | 1.03 | 0.73 | 0.78 | 0.37 |
EPS Diluted | 1.15 | -0.15 | 0.59 | 0.75 | 0.52 | 1.10 | 0.67 | 0.94 | 1.03 | 0.73 | 0.78 | 0.37 |
Weighted Avg Shares Out | 74.60M | 74.60M | 72.14M | 72.45M | 73.04M | 73.04M | 73.04M | 73.04M | 54.25M | 70.40M | 46.64M | 35.68M |
Weighted Avg Shares Out (Dil) | 74.60M | 74.60M | 74.60M | 73.93M | 73.93M | 73.04M | 73.04M | 73.04M | 54.25M | 70.40M | 46.64M | 35.68M |
Source: https://incomestatements.info
Category: Stock Reports